Career history of Robert DuFresne
Former positions of Robert DuFresne
| Companies | Position | Start | End |
|---|---|---|---|
| PACGEN LIFE SCIENCE CORPORATION | President | - | 2008-10-30 |
Transfer Technologies Commercialisation Capital
 Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Corporate Officer/Principal | - | - |
Azelon Pharmaceuticals, Inc.
 Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | President | 2003-05-13 | - |
Training of Robert DuFresne
| Harvard University | Masters Business Admin |
Statistics
International
| United States | 3 |
| Canada | 3 |
Operational
| President | 2 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Azelon Pharmaceuticals, Inc.
Azelon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azelon Pharmaceuticals, Inc. develops biopharmaceutical drugs for the treatment of osteoporosis. It develops parathyroid hormone analogs for the treatment of bone diseases, which are characterized by deficits in bone formation, including osteoporosis, orthopedic conditions and renal bone disease. The company was founded by Paul Morley and Godfrey Marchand in 2000 and is headquartered in West Conshohocken, PA. | Health Technology |
Transfer Technologies Commercialisation Capital
Transfer Technologies Commercialisation Capital Investment ManagersFinance T²C² (Transfer Technologies Commercialisation Capital) is a Montréal-based venture capital partnership. They were founded in 1997. | Finance |
Pacgen Life Science Corp.
 Pacgen Life Science Corp. BiotechnologyHealth Technology Pacgen Life Science Corp. is a life science technology company, which engages in the development and commercialization of biomedical products and services. It specializes in the operation of global commercial platform to market and distribute consumer health products developed by small business enterprises. The company focuses on oral care and skin care commercial rights. Pacgen Life Science was founded by Fred Huang and Chung Yu Wang on April 23, 2004 and is headquartered in Vancouver, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert DuFresne
- Experience
